ホーム › 多発性骨髄腫 › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける多発性骨髄腫の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1相
- City of Hope National Medical Center /ID# 280273, Duarte · 4マイル先
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
被験者募集中第1/2相
- City of Hope National Medical Center, Duarte · 4マイル先
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
被験者募集中第1相
- Research Site, Duarte · 4マイル先
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第3相
- City of Hope Duarte, Duarte · 4マイル先
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
被験者募集中第1/2相
- City of Hope - Duarte, Duarte · 4マイル先
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
被験者募集中第3相
- City of Hope Duarte, Duarte · 4マイル先
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
被験者募集中第4相
- City of Hope, Duarte · 4マイル先
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
被験者募集中第3相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1/2相
- Research Site, Duarte · 4マイル先
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
被験者募集中第1/2相
- Research Site, Duarte · 4マイル先
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
被験者募集中第1/2相
- City of Hope National Medical Center /ID# 273132, Duarte · 4マイル先
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
被験者募集中第1相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
被験者募集中
- City of Hope, Duarte · 4マイル先
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
被験者募集中第1相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
被験者募集中観察研究健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
被験者募集中観察研究健康なボランティア歓迎
- City of Hope, Duarte · 4マイル先
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
他の都市における多発性骨髄腫の試験
- New York City, NY60件の研究
- Boston, MA42件の研究
- Atlanta, GA41件の研究
- Houston, TX38件の研究
- Durham, NC37件の研究
- Nashville, TN32件の研究
- Denver, CO27件の研究
- Rochester, MN24件の研究
- St. Louis, MO24件の研究
- Columbus, OH24件の研究
- Chicago, IL22件の研究
- Seattle, WA22件の研究
Baldwin Parkにおける他の研究
- 乳がん45件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌38件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）33件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 胃癌22件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。